Stryker’s new CEO: Innovation teams now asking, “Who is going to pay for this?” (MedCityNews)
Just one month ago, Kevin Lobo took over the top spot at medical device maker Stryker Corp. On Monday, he explained the $8.5 billion corporation’s innovation strategy moving forward in his first public appearance as CEO at Cleveland Clinic’s Medical Innovation Summit.
Formerly president of J&J company Ethicon Endo-Surgery and then head of Stryker’s orthopedics unit, Lobo replaced chief financial officer Curt Hartman, who served as interim CEO following the resignation of Stephen MacMillen in February.
According to Lobo, the innovation culture at Stryker has changed dramatically over the past several years as providing clinical and economic evidence for new products has become critical. “We’re starting to broaden our lens from just looking at products to thinking about the overall procedural efficacy, to thinking about the customer experience and the patient experience,” he said. “And we’re starting to collaborate with customers and trying to understand what role can we play in assisting along the continuum of care.”
Stryker is also placing an emphasis on internal collaboration. The ma...
